Skip to main content
Corey Speers, MD, Radiation Oncology, Cleveland, OH, University Hospitals Cleveland Medical Center

CoreyWayneSpeersMDPhD

Radiation Oncology • Cleveland, OH

Breast Cancer

Professor, Vice Chair for Research, Co-Director of the Breast Oncology Program, Hennessy Hyland Master Clinician in Immunotherapy and New Drug Development, Director, Phase I Clinical Trials Program, Radiation Oncology, University Hospitals University Hospital Seidman Cancer Center and Case Western Reserve University

Join to view full profile

Dr. Speers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Speers' full profile

Already have an account?

Education & Training

  • University of Michigan Health System
    University of Michigan Health SystemResidency, Radiation Oncology, 2011 - 2015
  • Methodist Hospital (Houston)
    Methodist Hospital (Houston)Internship, Transitional Year, 2010 - 2011
  • Baylor College of Medicine
    Baylor College of MedicineClass of 2010

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2025
  • OH State Medical License
    OH State Medical License 2022 - 2024
  • American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Journal Articles

  • The Immune Landscape of Prostate Cancer and Nomination of PD-L2 as a Potential Therapeutic Target  
    Melody Xu, Felix Y Feng, Corey Speers, Shuang G Zhao, S Laura Chang, Journal of the National Cancer Institute

Press Mentions

  • Silicone-Based Film for Radiation Dermatitis: It Works, so Why Isn’t It Used?
    Silicone-Based Film for Radiation Dermatitis: It Works, so Why Isn’t It Used?March 13th, 2023
  • Some Breast Cancer Patients Can ‘Avoid Radiotherapy’ – Study
    Some Breast Cancer Patients Can ‘Avoid Radiotherapy’ – StudyJune 7th, 2022
  • Biomarker Guidance May Allow Patients Aged 55 or Older with Low-Grade Luminal a–type Breast Cancer to Avoid Radiation Therapy
    Biomarker Guidance May Allow Patients Aged 55 or Older with Low-Grade Luminal a–type Breast Cancer to Avoid Radiation TherapyJune 7th, 2022
  • Join now to see all

Professional Memberships

Other Languages

  • German

Hospital Affiliations

Dr. Corey Speers, Dr. Corey Speers, MD, Dr. C Speers, Dr. Corey Wayne Speers